-+ 0.00%
-+ 0.00%
-+ 0.00%

VISARA ANNOUNCES FIRST PATIENT DOSED IN ASCEND PHASE 2B TRIAL OF VIS-101 IN WET AMD

Reuters·11/18/2026 12:00:01

Please log in to view news